Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -22.70%1.04B | -13.16%717.53M | -29.24%387.06M | -27.21%2.05B | -38.85%1.35B | -35.63%826.3M | -22.62%547.02M | 19.41%2.81B | 15.11%2.21B | 1.24%1.28B |
| Refunds of taxes and levies | -53.82%342.95K | -77.15%169.72K | -97.54%18.06K | 917.15%22.28M | -40.76%742.63K | 23.67%742.63K | 47.06%733.43K | -68.16%2.19M | -45.08%1.25M | 409.63%600.51K |
| Cash received relating to other operating activities | -19.63%11.65M | -7.40%9.3M | 54.53%4.85M | -21.33%32.69M | -9.53%14.5M | -20.47%10.05M | 171.93%3.14M | -13.07%41.56M | -92.76%16.02M | -54.77%12.63M |
| Cash inflows from operating activities | -22.68%1.06B | -13.15%727M | -28.86%391.93M | -26.40%2.1B | -38.64%1.37B | -35.46%837.09M | -22.26%550.89M | 18.52%2.86B | 3.90%2.23B | 0.07%1.3B |
| Goods services cash paid | -1.23%571.97M | 20.54%449.19M | 8.60%312.57M | -56.59%673.85M | -28.21%579.09M | -23.39%372.65M | -37.86%287.82M | 105.26%1.55B | -6.23%806.64M | -19.97%486.46M |
| Staff behalf paid | -10.91%106.67M | -1.21%75.78M | 0.26%41.63M | -3.88%154.67M | -0.04%119.73M | -6.01%76.71M | 0.31%41.52M | -0.45%160.92M | -1.16%119.78M | -6.18%81.61M |
| All taxes paid | -47.79%190.98M | -46.56%154.8M | -68.72%47.05M | 37.39%521.72M | 18.87%365.78M | 46.97%289.64M | 30.84%150.42M | -17.11%379.75M | -15.13%307.72M | 25.05%197.08M |
| Cash paid relating to other operating activities | -10.47%176.02M | -12.55%109.82M | -3.75%63.55M | -10.27%229.75M | 12.13%196.6M | 1.32%125.58M | -5.35%66.02M | 6.29%256.05M | -5.37%175.34M | 7.07%123.94M |
| Cash outflows from operating activities | -17.09%1.05B | -8.67%789.59M | -14.84%464.8M | -32.73%1.58B | -10.52%1.26B | -2.76%864.58M | -20.82%545.78M | 45.27%2.35B | -7.83%1.41B | -8.17%889.09M |
| Net cash flows from operating activities | -90.43%9.96M | -127.65%-62.58M | -1,525.56%-72.87M | 2.89%522.78M | -87.24%104.04M | -106.74%-27.49M | -73.55%5.11M | -35.98%508.1M | 33.22%815.61M | 24.38%407.84M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 20.92%183.54M | 8.40%132.02M | --11.6M | -69.72%17.96M | --151.78M | --121.78M | ---- | --59.31M | ---- | ---- |
| Cash received from returns on investments | --3.24M | --3.24M | ---- | 4,860.54%304.13K | ---- | ---- | ---- | -99.93%6.13K | -98.98%5.78K | -98.97%5.78K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | 694.69%158.92M | ---- | ---- | ---- | --20M | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -25.52%74.48M | --74.48M |
| Cash inflows from investing activities | 23.06%186.78M | 11.06%135.26M | --11.6M | 123.40%177.18M | 103.77%151.78M | 63.49%121.78M | ---- | -43.29%79.31M | -43.20%74.49M | 141.94%74.49M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 103.97%9.29M | 130.76%7.63M | -4.95%1.4M | -92.30%32.04M | -98.86%4.56M | -99.17%3.31M | -46.30%1.47M | 1,982.10%416.2M | 19,881.89%399.07M | 61,884.35%398.84M |
| Cash paid to acquire investments | ---- | ---- | ---- | -61.77%22.02M | ---- | ---- | ---- | 188.00%57.6M | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.69%1M | -99.69%1M |
| Cash outflows from investing activities | 103.97%9.29M | 130.76%7.63M | -4.95%1.4M | -88.59%54.06M | -98.86%4.56M | -99.17%3.31M | -60.66%1.47M | 201.87%473.8M | 23.72%400.07M | 24.70%399.84M |
| Net cash flows from investing activities | 20.55%177.49M | 7.73%127.63M | 793.95%10.2M | 131.21%123.12M | 145.22%147.23M | 136.42%118.48M | 46.29%-1.47M | -2,205.63%-394.49M | -69.38%-325.58M | -12.25%-325.35M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -17.76%527.13M | -43.79%275.98M | -53.06%145.98M | 5.93%1.11B | -19.77%641M | -38.55%491M | -22.06%311M | 10.01%1.04B | 6.68%799M | 6.68%799M |
| Cash received relating to other financing activities | 3.60%207.2M | -24.30%151.39M | -85.92%31M | -21.11%380.78M | -8.22%200M | 61.93%200M | 129.60%220.09M | -41.14%482.68M | -51.84%217.92M | -69.12%123.51M |
| Cash inflows from financing activities | -12.68%734.33M | -38.15%427.37M | -66.68%176.98M | -2.62%1.49B | -17.30%841M | -25.10%691M | 7.32%531.09M | -29.82%1.53B | -15.36%1.02B | -19.71%922.51M |
| Borrowing repayment | 15.85%761.9M | -11.38%423.15M | -58.82%143.85M | -29.75%1.07B | -45.30%657.65M | -37.02%477.47M | -45.08%349.35M | 18.89%1.52B | 26.49%1.2B | 2.26%758.14M |
| Dividend interest payment | 17.44%219.07M | 33.21%76.08M | -12.31%30.12M | -31.19%332.27M | -56.03%186.54M | 0.77%57.12M | -1.20%34.35M | 37.57%482.88M | 125.19%424.23M | -39.43%56.68M |
| Cash payments relating to other financing activities | -88.47%31.26M | -94.15%12M | -56.72%88.25M | 1,018.65%586.24M | 19.88%271.2M | 33.26%205.09M | 32.31%203.9M | -93.39%52.41M | -16.63%226.22M | -48.38%153.89M |
| Cash outflows from financing activities | -9.25%1.01B | -30.88%511.23M | -55.37%262.23M | -3.39%1.99B | -39.80%1.12B | -23.64%739.67M | -28.78%587.6M | -15.12%2.06B | 31.38%1.85B | -14.51%968.71M |
| Net cash flows from financing activities | -1.28%-277.9M | -72.29%-83.86M | -50.85%-85.25M | 5.59%-501.15M | 67.17%-274.39M | -5.34%-48.67M | 82.88%-56.51M | -113.61%-530.8M | -300.43%-835.77M | -390.52%-46.2M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | -38.22%16.1K | ---- | ---- | ---- | -69.33%26.06K | ---- | ---- |
| Net increase in cash and cash equivalents | -291.33%-90.46M | -144.45%-18.81M | -179.76%-147.91M | 134.70%144.77M | 93.31%-23.12M | 16.62%42.32M | 83.14%-52.87M | -178.98%-417.16M | -263.64%-345.75M | -32.73%36.29M |
| Add:Begin period cash and cash equivalents | 43.20%479.87M | 43.20%479.87M | 43.20%479.87M | -55.45%335.1M | -55.45%335.1M | -55.45%335.1M | -55.45%335.1M | 235.70%752.26M | 235.70%752.26M | 235.70%752.26M |
| End period cash equivalent | 24.82%389.41M | 22.16%461.06M | 17.62%331.96M | 43.20%479.87M | -23.25%311.98M | -52.14%377.41M | -35.67%282.23M | -55.45%335.1M | -6.63%406.51M | 183.62%788.54M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxi Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.